Piper Sandler Downgrades VectivBio Holding to Neutral, Lowers Price Target to $17
Portfolio Pulse from richadhand@benzinga.com
Piper Sandler analyst Christopher Raymond downgraded VectivBio Holding (NASDAQ:VECT) from Overweight to Neutral and lowered the price target from $25 to $17.
May 23, 2023 | 12:25 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Piper Sandler downgraded VectivBio Holding (VECT) to Neutral and reduced the price target from $25 to $17.
The downgrade from Overweight to Neutral by Piper Sandler's analyst Christopher Raymond indicates a less optimistic outlook for VectivBio Holding. The lowered price target from $25 to $17 suggests a reduced potential upside for the stock, which may negatively impact its short-term price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100